Finance

Lists
Why is RXRX up 4,56%?
Dive Deeper
RXRX:NASDAQ
Recursion Pharmaceuticals Inc
4,13 $
+4,56%
(+0,18) 1D
9 հոկ, 11:12:30 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RXRX...
Open
4,02 $
High
4,26 $
Low
3,89 $
Mkt. cap
2,21 մլրդ
Avg. vol.
23,73 մլն
Volume
10,57 մլն
52-wk high
7,18 $
52-wk low
2,77 $
EPS
-1,04 $
Beta
1,04
Shares outstanding
535,34 մլն
No. of employees
600
Open
4,02 $
High
4,26 $
Low
3,89 $
Mkt. cap
2,21 մլրդ
Avg. vol.
23,73 մլն
Volume
10,57 մլն
52-wk high
7,18 $
52-wk low
2,77 $
EPS
-1,04 $
Beta
1,04
Shares outstanding
535,34 մլն
No. of employees
600
News stories
From web sources and news partners
About Recursion Pharmaceuticals Inc
CEONajat Khan
Employees600
Founded2013
HeadquartersՍոլթ Լեյք Սիթի, Յուտա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to RXRX in the past 3 months
Buy
Buy
2
Hold
3
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for RXRX in the last 3 months.
Highest
Current 4,13 $
8,00 $ (+93,70%)
Average
6,65 $ (+61,02%)
Lowest
5,30 $ (+28,33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alec Stranahan
Bank of America Securities
Hold
Maintained
-
-
09/21/2026
Priyanka Grover
J.P. Morgan
Buy
Reiterated
-
-
09/15/2026
Sean Laaman
Morgan Stanley
Hold
Reiterated
5,30 $
+28,3%
08/17/2026
Brendan Smith
TD Cowen
Hold
Maintained
-
-
08/05/2026
Gil Blum
Needham
Buy
Maintained
8,00 $
+93,7%
08/05/2026
Last report
05 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,25 $ / -0,23 $
-6,84%miss
Revenue / Est. (USD)
7,67 մլն / 11,96 մլն
-35,89%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-3 135,32%
-304,24%
-1 815,57%
-1 708,02%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps